Critical Market Drivers Shaping the Outlook for Macular Degeneration Treatment Market from 2025-2034: Growing Retinal Disorder Incidence Propels Macular Degeneration Treatment Market
Discover trends, market shifts, and competitive outlooks for the macular degeneration treatment industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
#What Is the Current and Projected Market Size of the Macular Degeneration Treatment Market Through 2034?#_x000D_
The market for macular degeneration treatment has seen a significant expansion in recent years. Its size is projected to increase from $11.05 billion in 2024 to $12.42 billion in 2025, experiencing a compound annual growth rate (CAGR) of 12.4%. Factors contributing to this growth in the historical period include an increase in the elderly population, lifestyle alterations, few treatment choices, heightened awareness, and the advancement of healthcare infrastructure._x000D_
_x000D_
The market for treatments of macular degeneration is predicted to experience swift expansion in the coming years. The market is projected to increase to $19.06 billion by 2029, with a compound annual growth rate (CAGR) of 11.3%. The upswing during this forecast period can be linked to progress in research, escalated spending on healthcare, rising incident rates, customized medical treatments, and global movements for eye health. Significant trends during the forecast timeframe include an emphasis on neuroprotection and regeneration therapies, the growth of telemedicine and remote monitoring, personalized medical treatments, exploration of stem cell therapies, and patient-centered initiatives for awareness and schooling._x000D_
_x000D_
#Download a free sample to assess the report’s scope and structure:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=5799&type=smp_x000D_
_x000D_
#What Are the Core Growth Drivers Propelling the Macular Degeneration Treatment Market Forward?#_x000D_
The escalating impact of retinal disorders is anticipated to drive the expansion of the macular degeneration treatment market. These disorders damage crucial tissue and disrupt how individuals process visual data, causing blurred or missing vision. For example, the American Academy of Ophthalmology predicts that 7.32 million people in the United States will suffer from primary open-angle glaucoma by 2050. This term includes a range of eye conditions, and the largest prevalence is expected within groups aged 70-79 years (32%), women (50%), and Hispanics (50%). The biggest demographic within this is Hispanic men. As such, the rising impact of retinal disorders is fueling the development of the macular degeneration treatment market._x000D_
_x000D_
#What Segment Types Define the Macular Degeneration Treatment Market Structure?#_x000D_
The macular degeneration treatment market covered in this report is segmented –_x000D_
_x000D_
1) By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD_x000D_
2) By End User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals_x000D_
3) By Route of Administration: Oral, Injectable, Other Route of Administration_x000D_
4) By Types: Wet Macular Degeneration, Dry Macular Degeneration_x000D_
_x000D_
Subsegments:_x000D_
1) By Early-Stage AMD: Nutritional Supplements, Lifestyle Modification Treatments_x000D_
2) By Intermediate AMD: Anti-VEGF Injections, Photodynamic Therapy_x000D_
3) By Late-Stage AMD: Surgical Treatments, Advanced Anti-VEGF Therapies, Gene Therapy Options_x000D_
_x000D_
#Request customized data on this market:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=5799&type=smp_x000D_
_x000D_
#Which Geographic Areas Hold the Strongest Growth Potential in the Macular Degeneration Treatment Market?#_x000D_
North America was the largest region in the macular degeneration treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the macular degeneration treatment Market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Which Emerging Trends that Are Influencing theMacular Degeneration Treatment Industry Evolution?#_x000D_
Leading corporations in the realm of the macular degeneration treatment marketplace are concentrating on the creation of biosimilars for the treatment of age-related macular degeneration (AMD). These biosimilars, biological medicinal substances very akin to already approved reference products, do not demonstrate any clinically significant differences in their safety, purity, or potency. For instance, approaching May 2024, Biocon Biologics Ltd, indigenous to India, and Samsung Bioepis Co. Ltd, a company from South Korea, earned FDA Approvals for two novel biosimilars, namely Yesafili and Opuviz. Designed to inhibit the vascular endothelial growth factor (VEGF) responsible for irregular blood vessel growth in the eye, these biosimilars prevent the vision loss that conditions like AMD and diabetic retinopathy can cause. The FDA granted approval for these biosimilars following comparative studies that evidenced no notable differences between the efficacy or safety of Yesafili and Opuviz, as compared to Eylea. These tests included meticulous evaluations of the biosimilars’ pharmacokinetics and immunogenicity._x000D_
_x000D_
#View the full report here:#_x000D_
_x000D_
#What Is the Definition of the Macular Degeneration Treatment Market?#_x000D_
Macula refers to the central portion of the retina, a light-sensitive layer of tissue at the back of the eye. The macula is responsible for central vision. Degeneration of the macula, which affects the central part of the retina (the macula) and results in distortion or loss of central vision, occurs most commonly after the age of 60 and is referred to as age-related macular generation (AMD). The macular degeneration treatment is used to treat macular degeneration eye disease and slow the disease and prevent severe loss of vision._x000D_
_x000D_
#Purchase the full report and get a swift delivery:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5799_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 3156230293_x000D_
Asia +44 2071930708_x000D_
Europe +44 2071930708_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
